EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access · CC BY 4.0

Assessing the Acceptability of a Tenofovir-Based Rectal Microbicide Douche among Young Men who Have Sex with Men: Results from ATN-DREAM (ATN 163)

José A Bauermeister, Willey Lin, Jessica Webster, Louis L Listerud, Tyler Burgese, Allison Agwu, Jessica Coleman Lewis, Thuy Anderson, Lisa Hightow-Weidman, Craig Hendrix, Renata Arrington-Sanders

AIDS and Behavior · 2025

DOI: 10.1007/s10461-025-04763-2 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift AIDS and Behavior, 2025. Verfasst von José A Bauermeister und 10 weiteren Autor:innen. Beteiligte Einrichtung: University of Pennsylvania, Philadelphia, PA, USA. bjose@upenn.edu. Hauptthemen laut MEDLINE: Tenofovir, Homosexuality, Male, HIV Infections, Pre-Exposure Prophylaxis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Young men who have sex with men (YMSM) remain disproportionately affected by HIV, yet adherence to daily oral pre-exposure prophylaxis (PrEP) remains suboptimal. Rectal microbicides formulated as douches offer a behaviorally congruent alternative by leveraging existing douching practices. This study assessed the acceptability of a tenofovir-based rectal microbicide douche among YMSM. Eight YMSM (M = 20.9 years; range 18–24 years) participated in a Phase I, open-label, single-arm trial evaluating the safety, pharmacokinetics, and tolerability of a single 600 mg dose of tenofovir delivered in a 125mL rectal douche (NCT04686279). This mixed-methods study included post-dosing behavioral surveys and qualitative in-depth interviews (IDIs) to assess acceptability, tolerability, and perceptions of the product’s usability. Interviews were transcribed, coded, and analyzed thematically. Descriptive statistics summarized participant characteristics, douching behaviors, and willingness to use the product in different contexts. Participants reported high acceptability of the rectal microbicide douche, particularly its ease of use and integration into existing sexual health routines. Most (87.5%) indicated they would find the product acceptable for HIV prevention, and 75% reported they would likely use it before every receptive anal intercourse (RAI) event. The episodic dosing regimen was perceived as a benefit, especially for casual sexual encounters. Barriers included product design concerns, privacy, and cost. A rectal microbicide douche was highly acceptable among YMSM, supporting its potential as a novel HIV prevention strategy. Findings underscore the importance of behaviorally congruent interventions and highlight key considerations for future product development, including improved packaging, affordability, and accessibility. Trials Registration: NCT04686279.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TenofovirHomosexuality, MaleHIV InfectionsPre-Exposure ProphylaxisPatient Acceptance of Health CareAnti-HIV AgentsHumansMaleAdolescentYoung AdultAdministration, RectalInterviews as Topic

Stichwörter der Autor:innen

Adolescent healthPre-exposure prophylaxis (PrEP)PreventionReceptive anal intercourse

Substanzen

TenofovirAnti-HIV Agents

Autor:innen und Institutionen

  • University of Pennsylvania, Philadelphia, PA, USA. bjose@upenn.edu.
  • University of Pennsylvania, Philadelphia, PA, USA.
  • Johns Hopkins University, Baltimore, MD, USA.
  • Florida State University, Tallahassee, FL, USA.
  • Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Förderung

  • NICHD NIH HHS
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Child Health and Human Development

Zitieren

APA

Bauermeister, J. A., Lin, W., Webster, J., Listerud, L. L., Burgese, T., Agwu, A., Lewis, J. C., Anderson, T., Hightow-Weidman, L., Hendrix, C., & Arrington-Sanders, R. (2025). Assessing the Acceptability of a Tenofovir-Based Rectal Microbicide Douche among Young Men who Have Sex with Men: Results from ATN-DREAM (ATN 163). AIDS and Behavior. https://doi.org/10.1007/s10461-025-04763-2

Vancouver

Bauermeister JA, Lin W, Webster J, Listerud LL, Burgese T, Agwu A, et al. Assessing the Acceptability of a Tenofovir-Based Rectal Microbicide Douche among Young Men who Have Sex with Men: Results from ATN-DREAM (ATN 163). AIDS and Behavior. 2025. doi:10.1007/s10461-025-04763-2

BibTeX
@article{Bauermeister2025,
  author = {Bauermeister, José A and Lin, Willey and Webster, Jessica and Listerud, Louis L and Burgese, Tyler and Agwu, Allison and Lewis, Jessica Coleman and Anderson, Thuy and Hightow-Weidman, Lisa and Hendrix, Craig and Arrington-Sanders, Renata},
  title = {Assessing the Acceptability of a Tenofovir-Based Rectal Microbicide Douche among Young Men who Have Sex with Men: Results from ATN-DREAM (ATN 163)},
  journal = {AIDS and Behavior},
  year = {2025},
  doi = {10.1007/s10461-025-04763-2}
}
Kostenlos starten →